Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
369
Price
$51.48
Total Value
$18,996.97
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Jul 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jul 21, 2026 |
| Shares Sold | 369 |
| Price per Share | $51.48 |
| Total Value | $18,996.97 |
| Shares Owned After | 51,379 |
| Derivative | No |
| Accession Number | 0001882764-26-000006 |
| Document | View SEC Filing |